Rajiv Pandit, MD
Otolaryngology · Dallas, TXNPI 1356317655
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $56,744 of the $70,502 with a category attached, or 80.5%. 22 manufacturers reported payments, led by Intersect ENT, Inc. at 53.9% of the total. Reporting peaked in 2021 at $30,870 and has fallen 81.2% since, to $5,812 in 2025. Among otolaryngology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 197 payments — averaging $357.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intersect ENT, Inc.$38K
- Medtronic$29K
- Stryker$1K
- Inspire Medical Systems, Inc.$359
- Aerin Medical Inc.$349
- Kaleo, Inc.$343
- plus $1K from 16 others
What the payments were for
- Consulting fees$4,8737%
- Speaking & faculty fees$56,74480%
- Travel & lodging$3,2325%
- Food & beverage$5,6198%
- Education$340%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intersect ENT, Inc. | 27 | $38,032 |
| Medtronic | 29 | $28,726 |
| Stryker | 43 | $1,319 |
| Inspire Medical Systems, Inc. | 5 | $359 |
| Aerin Medical Inc. | 16 | $349 |
| Kaleo, Inc. | 21 | $343 |
| Olympus America Inc. | 10 | $250 |
| Sanofi-aventis U.S. LLC | 11 | $229 |
| Sanofi | 9 | $215 |
| KARL Storz Endoscopy-america | 2 | $168 |
| Acclarent, Inc | 5 | $114 |
| Regeneron Healthcare Solutions, Inc. | 4 | $92 |
| Alk-abello, Inc | 3 | $84 |
| Hikma Pharmaceuticals USA | 2 | $35 |
| Amgen | 1 | $34 |
| AstraZeneca | 2 | $32 |
| Carestream Dental, LLC | 1 | $31 |
| Neurent Medical Limited | 2 | $29 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $29 |
| Merck | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
| Ambu Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROPEL$11,211
- VenSure Balloon Dilation System$5,850
- SINUVA$1,492
- Inspire$291
- ENTELLUS - XPRESS ENT DILATION SYSTEM$170
- LATERA$165
- SCOPIS ENT$153
- CCD VIDEO RHINO-LARYNGOSCOPE, NTSC$117
How this compares
$70,502 in reported general payments places this provider in the 95th percentile of 729 otolaryngology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 20 | $210 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $75 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Dallas
- Naren VenkatesanDallas$35K
- Michael MedinaDallas$19K
- Marc DeanFort Worth$486K
- Amber LuongHouston$426K
- Arjuna KuperanHouston$348K
- Ronald KuppersmithCollege Station$325K
- Ron KarniHouston$317K
- Philip ChenSan Antonio$305K
- Jordan RihaniSouthlake$280K
- Keith MathenyFrisco$269K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.